🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UPDATE 2-NYSE Q3 beats consensus, sells Liffe U.S. stake

Published 10/30/2009, 05:32 AM
Updated 10/30/2009, 05:36 AM
UBSN
-
MS
-
NYX
-
GC
-

* Q3 net earnings at $125 million or $0.48 per diluted share

* Compares to I/B/E/S consensus of $119.8 million

* Sells a "significant equity" stake in NYSE Liffe U.S. (Adds details)

By Daisy Ku

LONDON, Oct 30 (Reuters) - NYSE Euronext said on Friday it is selling a "significant equity interest" in its derivatives exchange NYSE Liffe U.S., as it posted a 28-percent drop in third-quarter earnings.

The bourse will remain the biggest shareholder of the U.S. part of NYSE Liffe, it said.

NYSE Euronext's third-quarter net income, at $125 million, outperformed market expectations, despite lower overall trading volumes, thanks to NYSE Liffe Clearing revenues and a 10 percent drop in fixed operating expenses.

Underlying fixed operating expenses, excluding the impact of mergers and acquisitions, foreign exchange fluctuations and investments in new businesses, were down $121 million.

A Thomson Reuters I/B/E/S consensus estimate was for a profit of $119.8 million. The year-ago number was $174 million.

Chief Executive Officer Duncan Niederauer said the bourse continued to see stabilization in its core businesses.

NYSE Euronext said it was selling the stake in NYSE Liffe U.S. to Goldman Sachs, Morgan Stanley, UBS, Citadel Securities and GETCO, to accelerate the growth of its U.S. futures exchange. (Reporting by Daisy Ku; Editing by Rupert Winchester)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.